Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

The RSV vaccine protects against RSV (respiratory syncytial virus), a common seasonal virus that infects the nose, throat, and lungs. While RSV typically causes mild, cold-like symptoms, it can lead ...

Credit: Getty Images. The FDA's Fast Track designation allows for accelerated development and review of the product. The Food and Drug Administration (FDA) has granted Fast Track designation to ...

Credit: Getty Images. RSV primarily affects children and older adults, and can lead to severe illness or death. Respiratory syncytial virus (RSV) affects infants, young children, and older adults, ...

Respiratory syncytial virus (RSV), a common infection in children and senior adults, can also infect nerve cells and trigger inflammation leading to nerve damage, according to a new Tulane University ...

What Is the RSV Vaccine? An RSV vaccine is a shot that protects you from respiratory syncytial virus (RSV), which infects your lungs and respiratory tract. Most cases of RSV are mild, but they can be ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...